首页> 美国卫生研究院文献>Journal of Virology >Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S Protein
【2h】

Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S Protein

机译:从严重急性呼吸系统综合症冠状病毒带有切面S蛋白的细胞表面进入如带有切面S蛋白的假型病毒所揭示

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is known to take an endosomal pathway for cell entry; however, it is thought to enter directly from the cell surface when a receptor-bound virion spike (S) protein is affected by trypsin, which induces cleavage of the S protein and activates its fusion potential. This suggests that SARS-CoV bearing a cleaved form of the S protein can enter cells directly from the cell surface without trypsin treatment. To explore this possibility, we introduced a furin-like cleavage sequence in the S protein at amino acids 798 to 801 and found that the mutated S protein was cleaved and induced cell fusion without trypsin treatment when expressed on the cell surface. Furthermore, a pseudotype virus bearing a cleaved S protein was revealed to infect cells in the presence of a lysosomotropic agent as well as a protease inhibitor, both of which are known to block SARS-CoV infection via an endosome, whereas the infection of pseudotypes with an uncleaved, wild-type S protein was blocked by these agents. A heptad repeat peptide, derived from a SARS-CoV S protein that is known to efficiently block infections from the cell surface, blocked the infection by a pseudotype with a cleaved S protein but not that with an uncleaved S protein. Those results indicate that SARS-CoV with a cleaved S protein is able to enter cells directly from the cell surface and agree with the previous observation of the protease-mediated cell surface entry of SARS-CoV.
机译:众所周知,严重急性呼吸系统综合症(SARS)冠状病毒(SARS-CoV)会通过内体途径进入细胞。然而,当胰蛋白酶影响受体结合的病毒粒子尖峰(S)蛋白时,可以认为它直接从细胞表面进入,从而诱导S蛋白裂解并激活其融合潜能。这表明带有S蛋白裂解形式的SARS-CoV可以不经胰蛋白酶处理而直接从细胞表面进入细胞。为了探索这种可能性,我们在S蛋白的798至801位氨基酸处引入了弗林蛋白酶样切割序列,发现突变的S蛋白在细胞表面表达时无需胰蛋白酶处理即可被切割并诱导细胞融合。此外,揭示了一种带有裂解的S蛋白的假型病毒会在溶酶体和蛋白酶抑制剂的存在下感染细胞,这两种酶均已知可通过内体阻止SARS-CoV感染,而假单胞菌感染这些试剂可阻断未切割的野生型S蛋白。衍生自SARS-CoV S蛋白的七肽重复肽已知可有效阻断细胞表面的感染,可通过假酶切开的S蛋白阻止未感染S蛋白的假型感染。这些结果表明,具有切割的S蛋白的SARS-CoV能够直接从细胞表面进入细胞,并且与之前对蛋白酶介导的SARS-CoV进入细胞的观察结果一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号